Cargando…
Erratum to: A pilot study of toceranib/vinblastine therapy for canine transitional cell carcinoma
Autores principales: | Rippy, Sarah B., Gardner, Heather L., Nguyen, Sandra M., Warry, Emma E., Portela, Roberta F., Drost, William Tod, Hostnik, Eric T., Green, Eric M., Chew, Dennis J., Peng, Juan, London, Cheryl A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5203707/ https://www.ncbi.nlm.nih.gov/pubmed/28038672 http://dx.doi.org/10.1186/s12917-016-0934-y |
Ejemplares similares
-
A pilot study of toceranib/vinblastine therapy for canine transitional cell carcinoma
por: Rippy, Sarah B., et al.
Publicado: (2016) -
Maintenance therapy with toceranib following doxorubicin-based chemotherapy for canine splenic hemangiosarcoma
por: Gardner, Heather L., et al.
Publicado: (2015) -
Plasma cytokeratin‐18 concentrations as noninvasive biomarker of early gastrointestinal toxicosis in dogs receiving toceranib
por: Kovac, Rachel L., et al.
Publicado: (2018) -
c‐Kit Mutation and Localization Status as Response Predictors in Mast Cell Tumors in Dogs Treated with Prednisone and Toceranib or Vinblastine
por: Weishaar, K.M., et al.
Publicado: (2017) -
Combination vinblastine, prednisolone and toceranib phosphate for treatment of grade II and III mast cell tumours in dogs
por: Olsen, Jaime A., et al.
Publicado: (2018)